The largest database of trusted experimental protocols

7 protocols using reversine

1

XTT Cell Viability Assay for Reversine

Check if the same lab product or an alternative is used in the 5 most similar protocols
XTT cell viability assays were performed by first seeding 4000 LM2-4 cells into a 96-well tissue culture plate. After cells attached overnight the indicated concentrations of Reversine (Selleckchem) or vehicle (DMSO) were then added to the wells in 100 μL phenol-free complete DMEM medium. After 48 h, XTT substrate (Thermo Fisher Scientific) was added to the wells and incubated for 2 h before reading the A450 nm on a plate reader.
+ Open protocol
+ Expand
2

Synthesis and Storage Protocols for Cancer Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The TTK inhibitors NTRC 0066-0 [18 (link)], MPI-0479605 [20 (link)] and Mps-Bay2b [21 (link)] were synthesized according to published protocols. Reversine was purchased from Selleck Chemicals; S-trityl-L-cysteine (STLC) from Sigma Aldrich. The source of all other anti-cancer agents is provided in Supplementary Table 2 of Uitdehaag et al. [41 (link)]. All compounds were stored as powders and freshly dissolved in dimethyl sulfoxide (DMSO) as 10 mM stocks.
+ Open protocol
+ Expand
3

Cell Line Characterization and Maintenance

Check if the same lab product or an alternative is used in the 5 most similar protocols
HT1080 6TG cells were a kind gift from Eric Stanbridge (University of California, Irvine) and Saos-2 were provided by Roger Reddel (CMRI). IMR90 cells were purchased from ATCC and IMR90 E6E7 derived in the Karlseder laboratory. Phoenix cells were purchased from ATCC. Identity of all cell lines were verified by Cell Bank Australia using short tandem repeat profiling. HT1080 6TG, HeLa, Saos-2 and derivatives were cultured at 37 °C, 10% CO2, and atmospheric oxygen, in DMEM (Life Technologies) supplemented with 1% non-essential amino acids (Life Technologies), 1% Glutamax (Life Technologies), and 10% bovine growth serum (Hyclone). IMR90 and derivatives were cultured at 37 °C, 10% CO2, and 3% O2, in DMEM, supplemented with 1% non-essential amino acids, 1% Glutamax, 10% fetal bovine serum (Life Technologies). The following compounds were used in cell treatments: dimethyl sulfoxide (DMSO, Sigma-Aldrich), colcemid (Life Technologies), Taxol (Sigma), reversine (Selleck Chemicals), KU-55933 (Calbiochem), Hesperadin (Selleck chemicals), Aphidicolin (Sigma-Aldrich) and Hydroxyurea (Sigma-Aldrich). All cell lines were tested for mycoplasma contamination (MycoAlert, LT07-118, Lonza) and were found to be negative.
+ Open protocol
+ Expand
4

Fibroblast and Cancer Cell Culture Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human IMR-90 primary lung fibroblasts (ATCC) and their derivatives were grown in Glutamax-DMEM (Gibco) supplemented with 0.1 mM nonessential Amino Acids and 15% Fetal Bovine Serum. HT1080 6TG cells were grown in Glutamax-DMEM supplemented with 0.1 mM Nonessential Amino Acids and 10% Bovine Growth Serum. All cells were grown at 7.5% CO2 and 3% O2. Colcemid (Life Technologies), Taxol (A. G. Scientific), vinblastine (A. G. Scientific), dimethylenastron (A. G. Scientific), hesperadin (Selleck), reversine (Selleck) and camptothecin (Selleck) were used at indicated concentration. ATM inhibitor (KU-55933) (Tocris) was used at 10 μM. FACS analysis was performed as described27 . Cells were tested for mycoplasma contamination and found negative.
+ Open protocol
+ Expand
5

Fibroblast and Cancer Cell Culture Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human IMR-90 primary lung fibroblasts (ATCC) and their derivatives were grown in Glutamax-DMEM (Gibco) supplemented with 0.1 mM nonessential Amino Acids and 15% Fetal Bovine Serum. HT1080 6TG cells were grown in Glutamax-DMEM supplemented with 0.1 mM Nonessential Amino Acids and 10% Bovine Growth Serum. All cells were grown at 7.5% CO2 and 3% O2. Colcemid (Life Technologies), Taxol (A. G. Scientific), vinblastine (A. G. Scientific), dimethylenastron (A. G. Scientific), hesperadin (Selleck), reversine (Selleck) and camptothecin (Selleck) were used at indicated concentration. ATM inhibitor (KU-55933) (Tocris) was used at 10 μM. FACS analysis was performed as described27 . Cells were tested for mycoplasma contamination and found negative.
+ Open protocol
+ Expand
6

Tumorsphere Formation Assay in Methylcellulose

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary tumorsphere formation in methylcellulose was assessed in cells grown under anchorage-independent conditions. LM2-4 cells (10,000) were cultured in 0.9 mL of 1% methylcellulose/complete DMEM medium in ultra-low adhesion 24-well dishes (Corning, Corning, NY, USA) and cells cultured for 8–10 days. Cells were treated with vehicle (DMSO) or the indicated doses of SP600125, JNK–IN–8, or Reversine (all from Selleckchem) concurrent with embedding in methylcellulose. Primary tumorspheres were assessed by counting colonies consisting of at least 6 cells from 4 fields per well with a 10x objective.
+ Open protocol
+ Expand
7

Reversine, HDAC, and EZH2 Inhibitor Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated with reversine (Cayman Chemical Company) at a concentration of 0.5 µM for either 24 h (for MDA-MB-231) or 48 h (4T1). The HDAC inhibitor vorinostat (Sigma-Aldrich; also known as SAHA) was used at a concentration of 0.5 µM for 24 h, and the methyltransferase inhibitor GSK-126 (XcessBio; EZH2) was used at a concentration of 5 µM for 5 days. Long-term reversine treatment was done 24 h after cells were passaged, and the medium was replaced with normal cell medium after 48 h. GSK923295 (Selleck Chemicals) was used at the concentration of 50 nM for 24 h. DMSO was used as the vehicle control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!